Parsley compounds show potential in cancer research

Parsley is gaining attention in nutritional research due to its high concentration of apigenin and other antioxidant compounds that show potential in cancer research. Nutrition expert Alison Tierney notes that apigenin, a plant-derived flavonoid, has demonstrated the ability to influence cancer cell development in laboratory and animal studies by promoting apoptosis (programmed cell death) and slowing tumor growth.

While preclinical studies suggest apigenin may affect cancer cells more significantly than healthy cells, researchers caution that most current evidence is derived from laboratory settings. The doses used in these studies are often considerably higher than what is typically consumed in a standard serving of parsley.

Additionally, parsley contains other beneficial compounds such as quercetin, myricetin, and vitamins A and C. These substances provide antioxidant and anti-inflammatory properties that may help combat oxidative stress and chronic inflammation, both of which are linked to various diseases, including cancer.